Get started
Author

Stelios Kasikis

The MAGIC algorithm probability is a validated response biomarker of treatment of acute graft-versus-host disease
2019 · Hrishikesh K. Srinagesh, Umut Özbek, et al. · Blood Advances · 111
PDF
Effective treatment of low-risk acute GVHD with itacitinib monotherapy
2022 · Aaron Etra, Alexandra Capellini, et al. · Blood · 42
PDF
Biomarker-guided preemption of steroid-refractory graft-versus-host disease with α-1-antitrypsin
2020 · Stephanie C. Gergoudis, Zachariah DeFilipp, et al. · Blood Advances · 38
PDF
Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease
2023 · Monzr M. Al Malki, Kaitlyn London, et al. · Blood Advances · 25
PDF
The MAGIC algorithm probability predicts treatment response and long-term outcomes to second-line therapy for acute GVHD
2024 · Zachariah DeFilipp, Haesook T. Kim, et al. · Blood Advances · 23
PDF
Evaluation of Elafin as a Prognostic Biomarker in Acute Graft-versus-Host Disease
2021 · Makda Getachew Zewde, George Morales, et al. · Transplantation and Cellular Therapy · 20
Flares of acute graft-versus-host disease: a Mount Sinai Acute GVHD International Consortium analysis
2024 · Yu Akahoshi, Nikolaos Spyrou, et al. · Blood Advances · 18
PDF
Current and Emerging Targeted Therapies for Acute Graft-Versus-Host Disease
2020 · Stelios Kasikis, Aaron Etra, et al. · BioDrugs · 17
Mesenchymal stromal cell therapy induces high responses and survival in children with steroid refractory GVHD and poor risk biomarkers
2021 · Stelios Kasikis, Janna Baez, et al. · Bone Marrow Transplantation · 12
A Day 14 Endpoint for Acute GVHD Clinical Trials
2024 · Nikolaos Spyrou, Yu Akahoshi, et al. · Transplantation and Cellular Therapy · 10
The MAGIC Algorithm Probability (MAP) Is a Validated Response Biomarker of Treatment for Acute Graft-Versus-Host Disease
2020 · Hrishikesh K. Srinagesh, Umut Ozbek, et al. · Transplantation and Cellular Therapy · 2
The MAGIC Algorithm Probability Predicts Treatment Response and Long-Term Outcomes to Second-Line Therapy for Acute Gvhd
2024 · Zachariah DeFilipp, Haesook T Kim, et al. · Transplantation and Cellular Therapy · 1
Impact of a respiratory panel on the diagnosis and management of acute chest syndrome in pediatric patients with sickle cell disease: A single-center retrospective study
2025 · Yaoping Zhang, Stelios Kasikis, et al. · Pediatric Hematology Oncology Journal
Case 1: Fever in a 40-day-old Infant
2023 · Stelios Kasikis, Maame Hayfron, et al. · Pediatrics in Review
A Day 14 Endpoint for Acute Gvhd Clinical Trials
2023 · Nikolaos Spyrou, Yu Akahoshi, et al. · Blood
PDF
Effective Treatment of Low Risk Acute Gvhd with Itacitinib Monotherapy
2022 · Alexandra Capellini, Aaron Etra, et al. · Blood
Prognostic Value of Elafin in Acute Graft-Versus-Host Disease
2021 · Makda Getachew Zewde, George Morales, et al. · Blood
Works count: 17
Citation count: 319
H-index: 10
I10-index: 10
Year
Topic
Type